Oppenheimer & Co’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$245K Sell
8,888
-1,331
-13% -$36.7K ﹤0.01% 1423
2025
Q1
$290K Buy
10,219
+255
+3% +$7.23K ﹤0.01% 1300
2024
Q4
$414K Sell
9,964
-27,823
-74% -$1.16M 0.01% 1137
2024
Q3
$2.53M Sell
37,787
-5,144
-12% -$344K 0.04% 476
2024
Q2
$5.1M Buy
42,931
+2,626
+7% +$312K 0.08% 270
2024
Q1
$4.29M Buy
40,305
+8,214
+26% +$875K 0.07% 307
2023
Q4
$3.19M Sell
32,091
-12,611
-28% -$1.25M 0.06% 369
2023
Q3
$4.62M Buy
44,702
+769
+2% +$79.4K 0.1% 245
2023
Q2
$5.34M Sell
43,933
-2,766
-6% -$336K 0.11% 219
2023
Q1
$7.17M Buy
46,699
+1,606
+4% +$247K 0.15% 157
2022
Q4
$8.1M Sell
45,093
-3,989
-8% -$717K 0.18% 129
2022
Q3
$5.8M Sell
49,082
-3,663
-7% -$433K 0.14% 181
2022
Q2
$7.53M Sell
52,745
-14,369
-21% -$2.05M 0.16% 138
2022
Q1
$11.6M Buy
67,114
+7,316
+12% +$1.26M 0.21% 94
2021
Q4
$15.2M Sell
59,798
-8,968
-13% -$2.28M 0.27% 73
2021
Q3
$26.5M Sell
68,766
-21,558
-24% -$8.3M 0.5% 28
2021
Q2
$21.2M Sell
90,324
-8,470
-9% -$1.99M 0.38% 47
2021
Q1
$12.9M Buy
98,794
+25,539
+35% +$3.34M 0.26% 82
2020
Q4
$7.65M Sell
73,255
-93
-0.1% -$9.72K 0.16% 135
2020
Q3
$5.19M Buy
73,348
+4,298
+6% +$304K 0.13% 171
2020
Q2
$4.43M Buy
69,050
+29,558
+75% +$1.9M 0.11% 198
2020
Q1
$1.18M Buy
+39,492
New +$1.18M 0.04% 468